New Bascom Ventures capital fund is premised on University of Wisconsin alumni pride

The secret ingredient to building a robust investment fund for startups might just be Badger pride. That’s the idea behind a new venture capital fund called Bascom Ventures, anyway. The 10-week-old endeavor is fundraising from University of Wisconsin alumni to create a pool of millions of dollars to go toward startups with UW alumni at […]

Osage Venture Partners Closes $90M Fund

Osage Venture Partners (OVP), today announced the closing of Osage Venture Partners IV, a $90 million fund focused on investing in early-stage, business-to-business (B2B) software companies on the East Coast. OVP IV represents the latest fund executing on OVP’s decade-long strategy of backing exceptional East Coast entrepreneurs building leading B2B software companies that target large […]

Honeywell Launches New Venture Investment Fund Focused On Early-Stage, High-Growth Companies

Honeywell (NYSE: HON) today announced the launch of a new investment fund that will invest in early-stage, high-growth technology companies that are strategically aligned to the Company’s portfolio and software capabilities. The initial fund size is expected to be approximately $100 million and investments will be made through Honeywell Venture Capital LLC, a wholly owned subsidiary […]

University of Navarra Vivet Therapeutics nabs Series A funds

Vivet Therapeutics (‘Vivet’), an emerging biotechnology company developing novel gene therapies for rare, inherited metabolic diseases, announced it has raised €37.5 million in a Series A financing round. The round involved a syndicate of leading international life sciences investors led by Novartis Venture Fund and Columbus Venture Partners, and including Roche Venture Fund, HealthCap, Kurma […]

New French Biotech Seed Fund Raises €65M-to support university innovation

Advent France Biotechnology, founded in 2015, has exceeded its initial fundraising target at the first closing. Its Seed-Fund I now counts with €64.75M that will be invested predominantly in France. The funds will back entrepreneurs and early-stage companies with the potential to develop first- or best-in-class innovations that address unmet medical needs. Advent France has declared […]

Company founded by two Marquette University researchers raises $26 million in funding 

Promentis Pharmaceuticals, a Milwaukee company co-founded by Drs. John Mantsch and David Baker, researchers from the Marquette University College of Health Sciences, raised $26 million, including $17.2 million in its third funding round. OrbiMed, F-Prime Capital Partners (formerly Fidelity Biosciences) and Aisling Capital were the lead investors. This is exceptional syndicate of investors, particularly for […]

Investing in the Midwest: opportunities abound

J.D. Vance, author of the bestseller Hillbilly Elegy, plans to move back to his native Ohio, in part to find venture capital opportunities in the area where he grew up. Is it worth following Vance into the Midwestern capital market? The Midwest has a lot to offer: A lower cost of living for workers, plenty […]